Literature DB >> 23042350

The ongoing battle against influenza: Drug-resistant influenza viruses: why fitness matters.

Anne Kelso1, Aeron C Hurt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23042350     DOI： 10.1038/nm.2954

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  14 in total

Review 1.  Neuraminidase inhibitors for influenza.

Authors:  Anne Moscona
Journal:  N Engl J Med       Date:  2005-09-29       Impact factor: 91.245

2.  Continued emergence and changing epidemiology of oseltamivir-resistant influenza A(H1N1)2009 virus, United Kingdom, winter 2010/11.

Authors:  A Lackenby; J Moran Gilad; R Pebody; S Miah; L Calatayud; S Bolotin; I Vipond; P Muir; M Guiver; J McMenamin; A Reynolds; C Moore; R Gunson; C Thompson; M Galiano; A Bermingham; J Ellis; M Zambon
Journal:  Euro Surveill       Date:  2011-02-03

3.  Permissive secondary mutations enable the evolution of influenza oseltamivir resistance.

Authors:  Jesse D Bloom; Lizhi Ian Gong; David Baltimore
Journal:  Science       Date:  2010-06-04       Impact factor: 47.728

4.  Reassortment of pandemic H1N1/2009 influenza A virus in swine.

Authors:  D Vijaykrishna; L L M Poon; H C Zhu; S K Ma; O T W Li; C L Cheung; G J D Smith; J S M Peiris; Y Guan
Journal:  Science       Date:  2010-06-18       Impact factor: 47.728

5.  Influenza viruses resistant to the antiviral drug oseltamivir: transmission studies in ferrets.

Authors:  M Louise Herlocher; Rachel Truscon; Stephanie Elias; Hui-Ling Yen; Noel A Roberts; Suzanne E Ohmit; Arnold S Monto
Journal:  J Infect Dis       Date:  2004-09-28       Impact factor: 5.226

6.  Emergence and spread of oseltamivir-resistant A(H1N1) influenza viruses in Oceania, South East Asia and South Africa.

Authors:  Aeron C Hurt; Joanne Ernest; Yi-Mo Deng; Pina Iannello; Terry G Besselaar; Chris Birch; Philippe Buchy; Malinee Chittaganpitch; Shu-Chun Chiu; Dominic Dwyer; Aurélie Guigon; Bruce Harrower; Ip Peng Kei; Tuckweng Kok; Cui Lin; Ken McPhie; Apandi Mohd; Remigio Olveda; Tony Panayotou; William Rawlinson; Lesley Scott; David Smith; Holly D'Souza; Naomi Komadina; Robert Shaw; Anne Kelso; Ian G Barr
Journal:  Antiviral Res       Date:  2009-03-24       Impact factor: 5.970

7.  A computational-experimental approach identifies mutations that enhance surface expression of an oseltamivir-resistant influenza neuraminidase.

Authors:  Jesse D Bloom; Jagannath S Nayak; David Baltimore
Journal:  PLoS One       Date:  2011-07-20       Impact factor: 3.240

8.  Oseltamivir-resistant pandemic (H1N1) 2009 virus infections, United States, 2010-11.

Authors:  Aaron D Storms; Larisa V Gubareva; Su Su; John T Wheeling; Margaret Okomo-Adhiambo; Chao-Yang Pan; Erik Reisdorf; Kirsten St George; Robert Myers; Jason T Wotton; Sara Robinson; Brandon Leader; Martha Thompson; Marjorie Shannon; Alexander Klimov; Alicia M Fry
Journal:  Emerg Infect Dis       Date:  2012-02       Impact factor: 6.883

9.  Oseltamivir-resistant influenza virus A (H1N1), Europe, 2007-08 season.

Authors:  Adam Meijer; Angie Lackenby; Olav Hungnes; Bruno Lina; Sylvie van-der-Werf; Brunhilde Schweiger; Matthias Opp; John Paget; Jan van-de-Kassteele; Alan Hay; Maria Zambon
Journal:  Emerg Infect Dis       Date:  2009-04       Impact factor: 6.883

10.  Enzymatic properties of the neuraminidase of seasonal H1N1 influenza viruses provide insights for the emergence of natural resistance to oseltamivir.

Authors:  Marie-Anne Rameix-Welti; Vincent Enouf; Frédérique Cuvelier; Patricia Jeannin; Sylvie van der Werf
Journal:  PLoS Pathog       Date:  2008-07-25       Impact factor: 6.823
View more
  18 in total

1.  Pharmacological Characterization of the Spectrum of Antiviral Activity and Genetic Barrier to Drug Resistance of M2-S31N Channel Blockers.

Authors:  Chunlong Ma; Jiantao Zhang; Jun Wang
Journal:  Mol Pharmacol       Date:  2016-07-06       Impact factor: 4.436

2.  Competitive fitness of influenza B viruses with neuraminidase inhibitor-resistant substitutions in a coinfection model of the human airway epithelium.

Authors:  Andrew J Burnham; Jianling Armstrong; Anice C Lowen; Robert G Webster; Elena A Govorkova
Journal:  J Virol       Date:  2015-02-11       Impact factor: 5.103

Review 3.  Alternative antiviral approaches to combat influenza A virus.

Authors:  Ka Heng Wong; Sunil K Lal
Journal:  Virus Genes       Date:  2022-10-19       Impact factor: 2.198

4.  Discovery of Potent Antivirals against Amantadine-Resistant Influenza A Viruses by Targeting the M2-S31N Proton Channel.

Authors:  Fang Li; Chunlong Ma; Yanmei Hu; Yuanxiang Wang; Jun Wang
Journal:  ACS Infect Dis       Date:  2016-09-22       Impact factor: 5.084

5.  Host versus flu: antibodies win a round?

Authors:  Christopher B Brooke; Jonathan W Yewdell
Journal:  Nat Struct Mol Biol       Date:  2013-03       Impact factor: 15.369

6.  The Tie2-agonist Vasculotide rescues mice from influenza virus infection.

Authors:  Michael G Sugiyama; Susan M Armstrong; Changsen Wang; David Hwang; Howard Leong-Poi; Andrew Advani; Suzanne Advani; Haibo Zhang; Katalin Szaszi; Arata Tabuchi; Wolfgang M Kuebler; Paul Van Slyke; Dan J Dumont; Warren L Lee
Journal:  Sci Rep       Date:  2015-06-05       Impact factor: 4.379

7.  Impact of the H275Y and I223V Mutations in the Neuraminidase of the 2009 Pandemic Influenza Virus In Vitro and Evaluating Experimental Reproducibility.

Authors:  Eric G Paradis; Lady Tatiana Pinilla; Benjamin P Holder; Yacine Abed; Guy Boivin; Catherine A A Beauchemin
Journal:  PLoS One       Date:  2015-05-20       Impact factor: 3.240

Review 8.  Understanding the Impact of Resistance to Influenza Antivirals.

Authors:  Edward C Holmes; Aeron C Hurt; Zuzana Dobbie; Barry Clinch; John S Oxford; Pedro A Piedra
Journal:  Clin Microbiol Rev       Date:  2021-02-10       Impact factor: 26.132

9.  Prolonged influenza virus shedding and emergence of antiviral resistance in immunocompromised patients and ferrets.

Authors:  Erhard van der Vries; Koert J Stittelaar; Geert van Amerongen; Edwin J B Veldhuis Kroeze; Leon de Waal; Pieter L A Fraaij; Roland J Meesters; Theo M Luider; Bart van der Nagel; Birgit Koch; Arnold G Vulto; Martin Schutten; Albert D M E Osterhaus
Journal:  PLoS Pathog       Date:  2013-05-23       Impact factor: 6.823

Review 10.  Clinical Implications of Antiviral Resistance in Influenza.

Authors:  Timothy C M Li; Martin C W Chan; Nelson Lee
Journal:  Viruses       Date:  2015-09-14       Impact factor: 5.048
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.